Clik here to view.
Cost-effectiveness of standard therapies for localized prostate cancer
According to a news item on the web site of the University of California, San Francisco, a new paper from a team lead by a UCSF researcher is, “The most comprehensive retrospective study ever conducted...
View ArticleClik here to view.
MRI-guided focused ultrasound in focal treatment of low-risk, localized...
In October last year, the US Food and Drug Administration approved the ExAblate MRI-guided focused ultrasound technology for the treatment of pain associated with cancer metastasis to bones, which is...
View ArticleClik here to view.
The state of prostate cancer management in Senegal, West Africa
We hear remarkably little about what is happening in the diagnosis and treatment of prostate cancer from developing countries in Africa and elsewhere, so a recent paper in Progrès en Urologie is of...
View ArticleClik here to view.
Understanding new tests for risk of clinically significant prostate cancer...
An article just published on the Medscape web site addresses data on the potential of GenomeDx Bioscence’s new “Decipher” test which “could” (according to one urologic oncologist) help prevent...
View ArticleClik here to view.
Current issues related to management of advanced prostate cacner in Europe
According to an article on PharmaTimes Online, a new report issued in Europe suggests that "European healthcare systems are failing to deliver the latest medical breakthroughs to men with advanced...
View ArticleClik here to view.
Sex after prostate cancer treatment — in the UK and elsewhere too
According to a story that first appeared on the BBC News web site last Friday, “Around 160,000 men in the UK have been left with little or no sex life after treatment for prostate cancer.” The story is...
View ArticleClik here to view.
The developing Cancer Survival Query System (CSQS) and its application to...
Just over a month ago we mentioned the CSQS in commenting on a Swedish paper (by Eloranta et al.) that dealt with prediction of the “crude” or “real world” probability of death from prostate cancer (as...
View ArticleClik here to view.
Sexual dysfunction among prostate cancer survivors — a new review article
In a newly published article in the Journal of Sexual Medicine, Chung and Brock offer a state of art review of the various types of sexual dysfunction identified among prostate cancer survivors and the...
View ArticleClik here to view.
Video discussion on the management of advanced prostate cancer
Many patients with advanced forms of prostate cancer may be interested in watching a new, 8-minute-long video discussion between a group of three urologists and a senior urology practice adminstrator...
View ArticleClik here to view.
First Cure Panel Talk Show on prostate cancer big success (in our opinion)
So we (and others) have been working recently with the editor of the Cure Panel Talk Show to help her in the development of their first, hour-long audio program on prostate cancer. (CureTalk has...
View ArticleClik here to view.
BRCA1/2, prostate cancer, and the Angelina Jolie effect
According to an article in The Sunday Times in the UK over the weekend, a well-known surgeon in the UK is claiming to have carried out “the first” radical prostatectomy on a man with no other indicator...
View ArticleClik here to view.
Recent utilization of active surveillance to defer treatment in Sweden
Although many US urologists and radiation oncologists consider that active surveillance is a highly appropriate form of management for low and very low-risk forms of prostate cancer, the actual use of...
View ArticleClik here to view.
Of cost, quality, and care for low-risk prostate cancer
A newly published study in the Annals of Internal Medicine has offered an analysis of the cost-effectiveness of “observation” as compared to immediate initial treatment for men diagnosed with low-risk,...
View ArticleClik here to view.
More on the screening, biopsy, treatment sequence
There is another iterestinng video discussion available on line on the Medscape web site … this one between Andrew Vickers, DPhil, of Memorial Sloan-Kettering Cancer Center, and Sigrid Carlsson, MD,...
View ArticleClik here to view.
Risk for hernia after first-line treatment for prostate cancer
The risk for an inguinal hernia after a radical prostatectomy for the treatment of localized prostate cancer is well known to most urologic surgeons, and patients are commonly advised to be cautious...
View ArticleClik here to view.
PTEN expression and risk for progressive disease in low-risk patients
A new paper by Cuzick and colleagues has suggested that loss of expression of the PTEN gene, which encodes for a protein known as phosphatase and tensin homologue (PTEN), may be significantly...
View ArticleClik here to view.
Empiric, first-line antibiotic therapy in men with an elevated PSA prior to...
It has been relatively common in recent years (although not recommended) for physicians to treat patients who present with an elevated PSA and a normal rectal exam (but no other clinical indicators of...
View ArticleClik here to view.
Intervew with three leading researchers at the NCI
Many readers may be interested in having a look at the text based on a recent interview carried out with four clinicians who specialize in research into the management of prostate cancer at the...
View ArticleClik here to view.
Did unequal use of ADT in treatment affect mortality rates in the ERSPC and...
A new article by Australian researchers in the Journal of the National Cancer Institute has suggested that the more widespread use of androgen deprivation therapy (ADT) among unscreened patients...
View ArticleClik here to view.
EAU updates guidelines on screening, diagnosis, and management of localized...
The European Association of Urology (EAU) has just updated its guideline document “EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent”. According...
View Article